FindMyKOL
Clinical trialNCT06458439RecruitingPhase 2Interventional

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

SponsorAbramson Cancer Center at Penn MedicineEnrollment31High-grade B-cell LymphomaLymphoma, Non-HodgkinRefractory Diffuse Large B-cell LymphomaRelapsed Diffuse Large B Cell LymphomaTransformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study investigates the feasibility and efficacy of epcoritamab treatment before CAR T cells. This study also investigates if, when patients have residual lymphoma after CAR T cells, epcoritamab can help to effectively treat that lymphoma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Elise Chong, MD

    Abramson Cancer Center at the University of Pennsylvania

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Abramson Cancer Center at the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Elise Chong, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Epcoritamab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
24 Sept 2024
Primary completion
31 Oct 2027
Completion
31 Dec 2027
Last update posted
27 May 2026
Registered enrollment
31
Registry id
NCT06458439
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.